The demonstration in vivo of specific binding sites for neuroleptic drugs in mouse brain.
D000818:Animals; D001058:Apomorphine / Q000494:pharmacology; D001921:Brain / Q000187:drug effects / Q000378:metabolism*; D002375:Catalepsy / Q000188:drug therapy; D002746:Chlorpromazine / Q000494:pharmacology; D003986:Dibenzocycloheptenes / Q000494:pharmacology; D004298:Dopamine / Q000378:metabolism; D006220:Haloperidol / Q000378:metabolism; D006801:Humans; D008297:Male; D051379:Mice; D010891:Piribedil / Q000494:pharmacology; D011807:Quinolizines / Q000494:pharmacology; D011954:Receptors, Dopamine / Q000378:metabolism; D011955:Receptors, Drug / Q000378:metabolism*; D013134:Spiperone / Q000378:metabolism / Q000627:therapeutic use; D013329:Structure-Activity Relationship; D014149:Tranquilizing Agents / Q000378:metabolism*
D003986:Dibenzocycloheptenes; D011807:Quinolizines; D011954:Receptors, Dopamine; D011955:Receptors, Drug; D014149:Tranquilizing Agents; D013134:Spiperone; D010891:Piribedil; D006220:Haloperidol; D001058:Apomorphine; D002746:Chlorpromazine; D004298:Dopamine